|

Risk-Based Lung Cancer Detection in COPD Patients

RECRUITINGN/ASponsored by Vejle Hospital
Actively Recruiting
PhaseN/A
SponsorVejle Hospital
Started2026-06-01
Est. completion2027-12
Eligibility
Age50 Years+
Healthy vol.Accepted

Summary

The goal of the interventional study is to evaluate whether risk-based stratification using the PLCOm2012 model and a machine learning (ML) model can identify patients with chronic obstructive pulmonary disease (COPD) who are at high risk of developing lung cancer and may benefit from low-dose computed tomography (LDCT) screening. The study population includes adults aged 50 years and older with COPD and a history of smoking attending an outpatient clinic. The main question it aims to answer are: \- What is the incidence of histopathologically confirmed lung cancer following risk-based stratification? Participants will: * Undergo lung cancer risk assessment using the PLCOm2012 model and an ML-based model based on clinical and laboratory data * Be referred for LDCT if classified as high-risk * Continue standard care if classified as low-risk * Be followed through electronic health records for up to six years to assess outcomes including lung cancer incidence, adherence to LDCT, time to imaging, healthcare utilization, costs, and safety

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosed with COPD
* Age ≥ 50 years
* Attendance at the outpatient Respiratory Medicine clinic, Vejle Hospital, University Hospital of Southern Denmark
* Smoking history (current or former smoker)
* Consent to translational research and biobank.

Exclusion Criteria:

* Previous diagnosis of lung cancer within the last five years.
* Active treatment for cancer within the last 12 months except non-melanoma skin cancer and carcinoma in situ cervicis uteri.
* Invasive methods to verify potential lung cancer not an option.
* Inability to provide informed consent.

Conditions5

COPDCOPD - Chronic Obstructive Pulmonary DiseaseCancerLung CancerLung Cancer (Diagnosis)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.